Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Non-Current Debt (2019 - 2025)

SRx Health Solutions (SRXH) has disclosed Non-Current Debt for 7 consecutive years, with $1.9 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Non-Current Debt changed N/A year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Jun 2025, changed N/A, and an annual FY2023 reading of $5.0 million, down 56.31% over the prior year.
  • Non-Current Debt was $1.9 million for Q2 2025 at SRx Health Solutions, up from $696000.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $19.6 million in Q1 2021 and bottomed at $696000.0 in Q3 2024.
  • Average Non-Current Debt over 5 years is $6.4 million, with a median of $4.8 million recorded in 2021.
  • The sharpest move saw Non-Current Debt skyrocketed 151.02% in 2022, then crashed 74.36% in 2024.
  • Year by year, Non-Current Debt stood at $4.6 million in 2021, then surged by 151.02% to $11.4 million in 2022, then crashed by 56.31% to $5.0 million in 2023, then tumbled by 86.08% to $696000.0 in 2024, then surged by 173.42% to $1.9 million in 2025.
  • Business Quant data shows Non-Current Debt for SRXH at $1.9 million in Q2 2025, $696000.0 in Q3 2024, and $5.0 million in Q4 2023.